Audrey Zhang, MD

Start Year
2020

Basics

Hometown
Cheshire, CT

Where did you attend college/university?
Harvard College

Where did you attend medical school?
NYU School of Medicine

What are your career goals?
I plan to pursue a career in academic medicine, joining my love of patient care, teaching and mentorship, and research that can make a difference.

Reflections on the Duke Program

What were you looking for in a residency program?
I was looking for rigorous clinical training, strong mentorship and coaching, and research opportunities. Importantly, I wanted to be in a program where people developed meaningful relationships with one another and valued each other as members of one community.

What are the strengths of the Duke Program?
I find it energizing to be in a program where everyone - from the interns to seasoned attendings - is constantly striving to learn and do better. One of the things that makes this possible is that the “Duke Family” is real - everyone is looking out for each other, and the culture is of building one another up and celebrating each other’s successes and growth.

About Duke University and Durham

What is the best thing about living in Durham and the Triangle?
Having moved from New York City, I love how many trails, parks, and green spaces there are to explore in the area. When I’m looking for a change in scenery, we’re within a reasonable radius of both beach and mountains.

What are your interests outside of medicine?
Going to local restaurants and bars, trying new recipes (with varying success), exploring new trails, watching movies, reading good books.
 

 

Publications

Zhang, Audrey D., Jeremy Puthumana, Alexander C. Egilman, Jason L. Schwartz, and Joseph S. Ross. “Demographic Characteristics of Participants in Trials Essential to US Food and Drug Administration Vaccine Approvals, 2010-2020.” Journal of General Internal Medicine 37, no. 3 (February 2022): 700–702. https://doi.org/10.1007/s11606-021-06670-3.

PMID
33660209
Full Text

Wallach, Joshua D., Audrey D. Zhang, Joshua J. Skydel, Victoria L. Bartlett, Sanket S. Dhruva, Nilay D. Shah, and Joseph S. Ross. “Feasibility of Using Real-world Data to Emulate Postapproval Confirmatory Clinical Trials of Therapeutic Agents Granted US Food and Drug Administration Accelerated Approval.” Jama Network Open 4, no. 11 (November 2021): e2133667. https://doi.org/10.1001/jamanetworkopen.2021.33667.

PMID
34751763
Full Text

Egilman, Alexander, Joshua D. Wallach, Jeremy Puthumana, Audrey D. Zhang, Jason L. Schwartz, and Joseph S. Ross. “Characteristics of Preapproval and Postapproval Studies of Vaccines Granted Accelerated Approval by the US Food and Drug Administration.” Journal of General Internal Medicine 36, no. 10 (October 2021): 3281–84. https://doi.org/10.1007/s11606-021-06943-x.

PMID
34131876
Full Text

Skydel, Joshua J., Audrey D. Zhang, Sanket S. Dhruva, Joseph S. Ross, and Joshua D. Wallach. “US Food and Drug Administration utilization of postmarketing requirements and postmarketing commitments, 2009-2018.” Clinical Trials (London, England) 18, no. 4 (August 2021): 488–99. https://doi.org/10.1177/17407745211005044.

PMID
33863236
Full Text

Dhodapkar, Meera, Audrey D. Zhang, Jeremy Puthumana, Nicholas S. Downing, Nilay D. Shah, and Joseph S. Ross. “Characteristics of Clinical Studies Used for US Food and Drug Administration Supplemental Indication Approvals of Drugs and Biologics, 2017 to 2019.” Jama Network Open 4, no. 6 (June 2021): e2113224. https://doi.org/10.1001/jamanetworkopen.2021.13224.

PMID
34110392
Full Text

Long, Aaron S., Audrey D. Zhang, Caitlin E. Meyer, Alexander C. Egilman, Joseph S. Ross, and Joshua D. Wallach. “Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review.” Jama Network Open 4, no. 5 (May 3, 2021): e215731. https://doi.org/10.1001/jamanetworkopen.2021.5731.

PMID
33956134
Full Text

Varma, Tanvee, Joshua D. Wallach, Jennifer E. Miller, Dominic Schnabel, Joshua J. Skydel, Audrey D. Zhang, Michaela A. Dinan, Joseph S. Ross, and Cary P. Gross. “Reporting of Study Participant Demographic Characteristics and Demographic Representation in Premarketing and Postmarketing Studies of Novel Cancer Therapeutics.” Jama Netw Open 4, no. 4 (April 1, 2021): e217063. https://doi.org/10.1001/jamanetworkopen.2021.7063.

PMID
33877309
Full Text

Puthumana, Jeremy, Alexander C. Egilman, Audrey D. Zhang, Jason L. Schwartz, and Joseph S. Ross. “Speed, Evidence, and Safety Characteristics of Vaccine Approvals by the US Food and Drug Administration.” Jama Internal Medicine 181, no. 4 (April 2021): 559–60. https://doi.org/10.1001/jamainternmed.2020.7472.

PMID
33170923
Full Text

MacGregor, Andrea, Audrey D. Zhang, Joshua D. Wallach, Joseph S. Ross, and Matthew Herder. “Disagreements Within the US Food and Drug Administration Regarding Approval of Novel Therapeutic Agents, 2011-2015.” Jama Network Open 3, no. 7 (July 2020): e209498. https://doi.org/10.1001/jamanetworkopen.2020.9498.

PMID
32706379
Full Text

Zhang, Audrey D., Jeremy Puthumana, Nicholas S. Downing, Nilay D. Shah, Harlan M. Krumholz, and Joseph S. Ross. “Assessment of Clinical Trials Supporting US Food and Drug Administration Approval of Novel Therapeutic Agents, 1995-2017.” Jama Network Open 3, no. 4 (April 2020): e203284. https://doi.org/10.1001/jamanetworkopen.2020.3284.

PMID
32315070
Full Text

Pages